UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Callan Capital LLC

Callan Capital LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 23.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,770 shares of the healthcare conglomerate’s stock after selling 542 shares during the period. Callan Capital LLC’s holdings in UnitedHealth Group were worth $895,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Prentice Wealth Management LLC increased its holdings in shares of UnitedHealth Group by 0.8% in the 4th quarter. Prentice Wealth Management LLC now owns 2,527 shares of the healthcare conglomerate’s stock valued at $1,278,000 after purchasing an additional 21 shares during the period. Deseret Mutual Benefit Administrators increased its holdings in UnitedHealth Group by 2.7% in the fourth quarter. Deseret Mutual Benefit Administrators now owns 1,029 shares of the healthcare conglomerate’s stock worth $521,000 after buying an additional 27 shares during the last quarter. Matauro LLC acquired a new position in UnitedHealth Group in the fourth quarter worth approximately $503,000. Bell Bank increased its holdings in UnitedHealth Group by 2.0% in the fourth quarter. Bell Bank now owns 7,324 shares of the healthcare conglomerate’s stock worth $3,705,000 after buying an additional 142 shares during the last quarter. Finally, Dividend Assets Capital LLC boosted its position in UnitedHealth Group by 3.1% during the fourth quarter. Dividend Assets Capital LLC now owns 22,463 shares of the healthcare conglomerate’s stock worth $11,363,000 after purchasing an additional 680 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.33% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

UNH has been the subject of a number of recent analyst reports. Truist Financial decreased their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Finally, KeyCorp reissued an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $465.58 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock has a fifty day moving average price of $519.27 and a two-hundred day moving average price of $560.54. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The firm has a market capitalization of $428.46 billion, a P/E ratio of 30.04, a P/E/G ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same period in the prior year, the company posted $5.83 earnings per share. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.